A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/1997
12/24/1997	CN1168698A Recombinant proteins of a Pakistani Strain of Hepatitis E and their use in diagnostic methods and vaccines
12/24/1997	CN1168696A RNA component of telomerase
12/24/1997	CN1168695A Inhibitor of stem cell proliferation and uses thereof
12/24/1997	CN1168693A Method for producing enhanced antigenic enteric bacteria and vaccines comprising same
12/24/1997	CN1168675A New compound
12/24/1997	CN1168674A Synthetic peptides and vaccines comprising same
12/24/1997	CN1168633A Boronic ester and acid compounds, synthesis and uses
12/24/1997	CN1168629A Adjuvant for a vaccine composition
12/24/1997	CN1036763C Pharmaceutical composition pharmaceutical granulate and process for their preparation
12/24/1997	CA2258547A1 Screening methods using microbial strain pools
12/24/1997	CA2258011A1 Vaccine to prevent streptococcal endocarditis
12/24/1997	CA2257482A1 Iodinated matrices for disinfecting biological fluids
12/23/1997	US5700933 3(2-oxazolidinone-3-yl)-2-azetidinone-1-acetic acid or ester for making carbacephalosporins antibiotics
12/23/1997	US5700928 Polynucleotide encoding saliva binding protein
12/23/1997	US5700922 PNA-DNA-PNA chimeric macromolecules
12/23/1997	US5700920 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates
12/23/1997	US5700838 Hydroxamic acid derivatives as metalloproteinase inhibitors
12/23/1997	US5700816 Antiarthritic agents
12/23/1997	US5700799 Oxazolidinone antimicrobials containing substituted diazine moieties
12/23/1997	US5700788 Treatment of hiv
12/23/1997	US5700787 Capsular polysaccharide immunomodulator
12/23/1997	US5700780 Oligopeptide viricides; ribonucleotide reductase enzyme inhibitor
12/23/1997	US5700779 Bradykinin antagonist peptides incorporating N-substituted glycines
12/23/1997	US5700635 HIV-1 gag cytotoxic T-lymphocyte epitope and method of use
12/23/1997	US5700461 Method for inhibiting HIV replication using IL-4
12/23/1997	CA2076430C Pyrrolidylthiocarbapenem derivative
12/20/1997	CA2208174A1 Squalene synthetase inhibitors
12/18/1997	WO1997047752A1 Chitinase materials and methods
12/18/1997	WO1997047744A2 T-cell selective interleukin-4 agonists
12/18/1997	WO1997047659A1 Synthetic polysaccharides, method for preparing same and pharmaceutical compositions containing said polysaccharides
12/18/1997	WO1997047653A1 Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
12/18/1997	WO1997047646A1 Helicobacter pylori adhesin binding group antigen
12/18/1997	WO1997047634A1 Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine
12/18/1997	WO1997047618A1 Substituted imidazoles having cytokine inhibitory activity
12/18/1997	WO1997047616A1 6,7-dihydroxy-8-methyl-4-oxo-4h-1-benzopyran-5-carboxylic acid with antibacterial activity
12/18/1997	WO1997047358A1 Synthetic hepatitis c genes
12/18/1997	WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997	WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997	WO1997047310A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions
12/18/1997	WO1997047301A1 Improved process for preparing potassium clavulanate
12/18/1997	WO1997047271A2 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	WO1997047270A2 Novel anti-viral compounds
12/18/1997	WO1997047201A1 Phosphate composition and its utilization
12/18/1997	WO1997047197A1 Compositions and methods for administering borrelia dna
12/18/1997	WO1997047194A1 Substituted cyclopentane compounds useful as neuraminidase inhibitors
12/18/1997	WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells
12/18/1997	CA2258560A1 Novel anti-viral compounds
12/18/1997	CA2258234A1 Phosphate composition and its utilization
12/18/1997	CA2258082A1 Cellular vaccines and immunotherapeutics and methods for their preparation
12/18/1997	CA2258016A1 Compositions and methods for administering borrelia dna
12/18/1997	CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection
12/18/1997	CA2257829A1 Chitinase materials and methods
12/18/1997	CA2257137A1 Synthetic hepatitis c genes
12/18/1997	CA2256459A1 T-cell selective interleukin-4 agonists
12/17/1997	EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family
12/17/1997	EP0812844A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof
12/17/1997	EP0812593A1 Vaccine compositions containing 3-0 deacylated monophosphoryl lipid a
12/17/1997	EP0812360A1 Human geranylgeranyl pyrophosphate synthetase
12/17/1997	EP0812358A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation
12/17/1997	EP0812357A1 A method for making heteromultimeric polypeptides
12/17/1997	EP0812323A1 Derivatives of 3-pyrrolidylidene-2-one-cephalosporines
12/17/1997	EP0812315A1 Pyrazolotetracyclines
12/17/1997	EP0812209A1 Cochleate phospholipids in drug delivery
12/17/1997	EP0812208A1 Pharmaceutical compositions for controlled release of soluble receptors
12/17/1997	EP0812206A1 Method for stimulating an immune response
12/17/1997	EP0812193A1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent
12/17/1997	EP0651649B1 Granulocyte colony-stimulating factor solution delivery method
12/17/1997	EP0649430B1 Derivatives of 16-membered ring antibiotic macrolides
12/17/1997	EP0559845B1 Use of compounds in preventing endotoxin shock
12/17/1997	EP0549729B1 Antiviral compounds and antihypertensive compounds
12/17/1997	EP0526543B1 Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
12/17/1997	EP0458901B1 Inhibiting transformation of cells having elevated purine metabolic enzyme activity
12/17/1997	CN1167777A Interferon conjugates
12/17/1997	CN1167765A Process for isolating or purifying cefonicid and process for preparing salts thereof
12/17/1997	CN1167618A Anti-beta-lactamase antibiotic composition
12/17/1997	CN1167567A Bacteriocidal antibacterial and bacteriostatic composition
12/17/1997	CN1036715C Cyclic peptide deriv. antifungal agents, and process for preparation thereof, and medicinal preparation contg. it
12/17/1997	CN1036714C Crystalline carbapenem deriv.
12/17/1997	CN1036713C Carbapenem deriv., its intermediate, preparing process and medicine composition contg. it
12/17/1997	CN1036712C Process for preparation of £1R-(1alpha, 2beta, 3alpha)\|-2-amino-9-£2,3-di(hydroxymethyl)-cyclobutyl\|-1,9-dihydro-6H-purin-6-one as antiviral agent
12/16/1997	US5698706 Heterocyclic amides and methods of use
12/16/1997	US5698698 Process for preparation of N-tert.butyl-decahydro-2- 2(R)-hydroxy-4-phenyl-3(S)-phthalimidobutyl!-(4aS,8aS)-isoquinoline-3(S)-carboxamide
12/16/1997	US5698687 Rna molecule containing modified nucloside
12/16/1997	US5698580 Antiviral agent containing benzodithiin derivative as active ingredient
12/16/1997	US5698577 Compositions of bicyclic β-lactams and uses thereof
12/16/1997	US5698574 5-membered heteroaryl-oxazolidinones
12/16/1997	US5698570 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime)pyrrolidine substituent and processes for preparing thereof
12/16/1997	US5698562 Consisting of trimethoprim, purified water, hydrochloric acid to dissolve drug, sucrose, flavoring to overcome bitter taste; pediatric dosing
12/16/1997	US5698546 Cyclic polyamines
12/16/1997	US5698532 Pyrimidine nucleosides and methods for treating viral infections with same
12/16/1997	US5698524 Preparing water soluble reaction product polymer of lignin and lignoid that have each been extracted from wood or wood-like materials under acidic and/or alkaline conditions
12/16/1997	US5698520 Peptide related to human programmed cell death and DNA encoding the same
12/16/1997	US5698432 Producing inactivated whole virus by treating with general inactivating agent, deaggregating agent, nucleic acid inactivating agent, then stabilizing with crosslinking agent
12/16/1997	US5698405 Coupling immunogenic agent with a carbohydrate polymer
12/16/1997	US5698403 Methods of detecting platelet-activating factor acetylhydrolase using antibodies
12/16/1997	US5698203 Attenuated viruse reactive with monoclonal antibody a27
12/11/1997	WO1997046697A3 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections
12/11/1997	WO1997046697A2 Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections
12/11/1997	WO1997046694A1 Process for producing high-molecular-weight compounds of phenolic compounds, etc. and use thereof
12/11/1997	WO1997046693A1 Virus-like particles useful as a vector for delivering nucleic acid

1 ... 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 ... 1798